Transcription of Clinical Guidelines ACP
{{id}} {{{paragraph}}}
Current Pharmacologic Treatment of Dementia: A Clinical PracticeGuideline from the American College of Physicians and the AmericanAcademy of Family PhysiciansAmir Qaseem, MD, PhD, MHA; Vincenza Snow, MD; J. Thomas Cross Jr., MD, MPH; Mary Ann Forciea, MD; Robert Hopkins Jr., MD;Paul Shekelle, MD, PhD; Alan Adelman, MD; David Mehr, MD, MS; Kenneth Schellhase, MD, MPH; Doug Campos-Outcalt, MD, MPA;Pasqualina Santaguida, PhD; Douglas K. Owens, MD, MS; and the Joint American College of Physicians/American Academy of FamilyPhysicians Panel on Dementia*Description:The American College of Physicians and AmericanAcademy of Family Physicians developed this guideline to presentthe available evidence on current pharmacologic treatmentof :The targeted literature search included evidence relatedto the effectiveness of 5 Food and Drug Administration approved pharmacologic therapies for dementia for outcomes inthe domains of cognition, global function, behavior/mood,andquality of life/activities of daily 1:Clinicians should base the decision to initiatea trial of therapy with a cholinesterase inhibitor or memantine onindividualized assessment.
Current Pharmacologic Treatment of Dementia Clinical Guidelines www.annals.org 4 March 2008 Annals of Internal Medicine Volume 148 • Number 5 371 24, 26, 27), 52 to 54 weeks (4, 5), 156 weeks ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Care guidelines, Guidelines, Clinical, Clinical care, Care, Clinical guidelines, Care Clinical Guidelines, Guidelines for Glaucoma Eye Care, Preventive Care Guidelines, Care Clinical, Medicaid, Clinical Practice Guidelines for Quality Palliative Care, Guidelines on Evidence-Based Psychological Practice, Evidence-Based Psychological Practice in